Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
Phase 2 pediatric NAFLD trial evaluating acarbose has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions [Phase 2]
A Phase 2 clinical trial evaluating nutritional interventions for non-alcoholic fatty liver disease in people with HIV was terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Effect of Omega-3 PUFA Supplementation in NAFLD Patients [Phase 2]
A Phase 2 trial assessing omega-3 PUFA supplementation in non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease [Phase 2]
This Phase 2 study in Non-alcoholic fatty liver disease investigates whether Helicobacter pylori eradication affects liver fat content; the …
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates [NA]
A completed clinical trial evaluated the impact of macrocomposition on nonalcoholic fatty liver disease in bariatric surgery candidates.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial evaluating Helicobacter pylori eradication in subjects with non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial evaluating Helicobacter pylori eradication in diabetic subjects with non-alcoholic fatty liver disease; the study is …
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial investigated the effect of a Mediterranean diet on non-alcoholic fatty liver disease (NAFLD).
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial evaluating Helicobacter pylori eradication in non-diabetic non-alcoholic fatty liver disease (NASH) has completed and…
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: Very Low Calorie Liquid Diet for Pre op Patients [NA]
Completed clinical trial evaluating a very low calorie liquid diet as a preoperative regimen for adults with morbid obesity and hepatic stea…
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: Iron Depletion Therapy for Type 2 DM and NAFLD [Phase 2]
A Phase 2 clinical trial update indicates completion of a study evaluating iron depletion therapy for individuals with non-alcoholic fatty l…
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine [Phase 1]
This update covers a Phase 1 trial evaluating Traditional Chinese Medicine for non-alcoholic fatty liver disease; the study status is comple…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery
This clinical trial update reports on assessing insulin resistance, non-alcoholic fatty liver disease, predictors of cardiovascular morbidit…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease [Phase 2]
A Phase 2 clinical trial evaluating the effect of omega-3 fatty acid supplements in patients with non-alcoholic fatty liver disease has comp…
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Effect on Liver Histology of Vitamin D in Patients With Non-alcoholic Steatohepatitis [Phase 3]
A Phase 3 clinical trial update evaluating the effect of Vitamin D on liver histology in patients with non-alcoholic steatohepatitis (a form…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD) [NA]
This document reports an ongoing clinical trial evaluating RGMA001 in patients with non-alcoholic fatty liver disease; the status is current…
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease [NA]
This clinical trial update reports on a completed pilot study evaluating whey protein supplementation for non-alcoholic fatty liver disease …
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: Study of INT-747 in Patients With Diabetes and Presumed NAFLD [Phase 2]
Phase 2 clinical trial update for obeticholic acid (INT-747) in patients with type 2 diabetes mellitus and presumed non-alcoholic fatty live…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Exercise Dose and Nonalcoholic Fatty Liver Disease [NA]
Clinical trial update noting the completion of a study evaluating how different exercise doses affect non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
A Phase 2 clinical trial comparing MitoQ to placebo for non-alcoholic fatty liver disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary Atherosclerosis
A clinical trial update addressing visceral adiposity, non-alcoholic fatty liver disease, and asymptomatic coronary atherosclerosis. The cur…
-
CLINICAL_TRIALS trial_result · 2010-07-13Clinical Trial Update: Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance [NA]
A completed clinical trial from Uppsala University investigates the role of dietary fatty acids in non-alcoholic fatty liver disease and ins…
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Obesity and Nonalcoholic Fatty Liver Disease [NA]
A completed clinical trial (NCT00262964) examining obesity and nonalcoholic fatty liver disease. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease [Phase 4]
A Phase 4 placebo-controlled trial is evaluating Lovaza (omega-3-acid ethyl esters) as a treatment for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2008-08-08Clinical Trial Update: Fatty Liver and Obstructive Sleep Apnea [NA]
The clinical trial investigating Non-Alcoholic Fatty Liver Disease and Obstructive Sleep Apnea has completed.